OrthoPediatrics (NASDAQ:KIDS) Trading 2.8% Higher

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) were up 2.8% during mid-day trading on Friday . The company traded as high as $30.72 and last traded at $30.72. Approximately 4,438 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 168,778 shares. The stock had previously closed at $29.88.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on KIDS. Needham & Company LLC reissued a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a report on Friday, August 16th. Truist Financial reissued a “hold” rating and set a $30.00 target price (down from $35.00) on shares of OrthoPediatrics in a research note on Thursday, August 8th.

OrthoPediatrics Price Performance

The business has a fifty day moving average price of $30.68 and a 200 day moving average price of $30.03. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96. The company has a market capitalization of $730.60 million, a price-to-earnings ratio of -31.94 and a beta of 1.19.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Monday, August 5th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.31) by $0.08. The firm had revenue of $52.80 million for the quarter, compared to analysts’ expectations of $52.40 million. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. On average, research analysts expect that OrthoPediatrics Corp. will post -0.96 earnings per share for the current fiscal year.

Insider Buying and Selling at OrthoPediatrics

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total value of $293,000.00. Following the sale, the general counsel now owns 77,304 shares of the company’s stock, valued at approximately $2,265,007.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 31.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On OrthoPediatrics

Several hedge funds have recently made changes to their positions in the business. CWM LLC boosted its holdings in OrthoPediatrics by 16,283.3% during the fourth quarter. CWM LLC now owns 983 shares of the company’s stock worth $32,000 after buying an additional 977 shares in the last quarter. Quest Partners LLC bought a new stake in shares of OrthoPediatrics during the 2nd quarter worth $34,000. EntryPoint Capital LLC grew its holdings in shares of OrthoPediatrics by 56.9% in the 1st quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after acquiring an additional 1,009 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of OrthoPediatrics during the second quarter worth $110,000. Finally, State Board of Administration of Florida Retirement System purchased a new stake in shares of OrthoPediatrics during the first quarter valued at $178,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.